SCHEMBL7974283

SCHEMBL7974283

O=c1[nH]c(-c2cccnc2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
KMT2A Q03164 1/20 0.53
HPGD P15428 2/20 0.51
DHPS P49366 2/20 0.47
CLK1 P49759 1/20 0.47
DYRK1A Q13627 1/20 0.47
CYP2E1 P05181 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2A6 P11509 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2B6 P20813 1/20 0.46
CYP2C19 P33261 1/20 0.46
CNOT7 Q9UIV1 1/20 0.45
PNP P00491 1/20 0.45
KDM4C Q9H3R0 2/20 0.44
MAPT P10636 1/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984766 0.90 HPGD (0.44) ALDH1A1SMN1; SMN2KMT2AHPGDDHPS
SCHEMBL7989418 0.90 SMN1; SMN2 (0.44) ALDH1A1SMN1; SMN2KMT2AHPGDDHPS
SCHEMBL7988656 0.90 NPY5R (0.44) ALDH1A1SMN1; SMN2KMT2AHPGDCNOT7
SCHEMBL7975265 0.90 SMN1; SMN2 (0.61) ALDH1A1SMN1; SMN2KMT2AHPGDCNOT7
SCHEMBL7986324 0.89 HPGD (0.48) ALDH1A1SMN1; SMN2KMT2AHPGDDHPS
SCHEMBL7985331 0.88 GRIN1 (0.45) ALDH1A1SMN1; SMN2KMT2AHPGDCNOT7
SCHEMBL7974236 0.88 ABCC8 (0.43) ALDH1A1SMN1; SMN2KMT2AHPGDDHPS
SCHEMBL7988931 0.88 GRIN1 (0.44) ALDH1A1SMN1; SMN2KMT2AHPGDCYP3A4
SCHEMBL7974445 0.87 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2KMT2AHPGDCNOT7
SCHEMBL7974041 0.87 KDM4E (0.51) ALDH1A1SMN1; SMN2KMT2AHPGDDHPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed